Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of ANG-3777 Injected Intravenously in Stable Adult Maintenance Hemodialysis Subjects

NCT04958187 is registered in ClinicalTrials.gov with Angion Biomedica Corp as lead sponsor.

NCT NCT04958187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04958187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of ANG-3777 Injected Intravenously in Stable Adult Maintenance Hemodialysis Subjects
Lead sponsor
Angion Biomedica Corp
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2021
Completion date
October 31, 2021
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis